[Re-treatment guideline of ranibizumab (genetical recombination) in the maintenance phase].

Clicks: 354
ID: 900
2009
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 10 articles by views in nippon ganka gakkai zasshi

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
tano2009[re-treatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tano, Yasuo;Ohji, Masahito;Ishibashi, Tatsuro;Shiraga, Fumio;Tokoro, Takashi;Yuzawa, Mitsuko;Yoshimura, Nagahisa;
Journal nippon ganka gakkai zasshi
Year 2009
DOI
DOI not found
URL URL not found
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.